English Journal

Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected? Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10): 948-55.

Sampablo I1, Carone M, Antoniu SA.
Expert opinion on pharmacotherapy.Expert Opin Pharmacother.2010 Jun;11(8):1439-41. doi: 10.1517/14656561003745916.
IMPORTANCE OF THE FIELD: Tiotropium bromidum is an inhaled long acting anticholinergic used as first line monotherapy in stable COPD due to its beneficial effects on the lung function, respiratory symptoms, quality of life or disease morbidity. However there is limited data on its effects on mortali
PMID 20446856

Long-term bronchodilator inhaled therapy in COPD: the role of tiotropium bromidum.

Antoniu SA1.
Reviews on recent clinical trials.Rev Recent Clin Trials.2009 May;4(2):89-98.
Chronic obstructive pulmonary disease (COPD) is an inflammatory disease of the lungs in which airways inflammation related mainly to smoking causes progressive airflow obstruction and chronic respiratory symptoms such as dyspnea or cough. COPD therapy in stable state is mainly inhalatory with bronch
PMID 19463105

[Treatment of bronchial conductance disorders in industrial workers with chronic obstructive lung diseases].

Rodionova VV.
Likars'ka sprava.Lik Sprava.2004 Dec;(8):79-85.
The use of broncholytic medications in industrial workers with chronic obstructive lung diseases (COLD) caused by harmful working conditions is considered by the authors. Classification of COLD, detailed information about the use of long-term beta2-agonists and cholinergic antagonists in treatment o
PMID 15771080